Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Orchid Island Capital Inc (ORC) Sinks On Reduced July Dividend

Page 1 of 2

Orchid Island Capital Inc (NYSE:ORC) saw its stock plunge to as low as $9.33 today or 18.73% lower than the $11.48 closing price of the shares yesterday after the specialty finance company announced a reduction of its monthly dividend for July 2015. The firm announced a $0.14 per share dividend for the month, a sizable 22.22% drop from the previous $0.18 per share monthly dividend, which had been paid out for over a year straight. “The reduction was the result of elevated prepayment speeds on mortgages underlying our portfolio,” Robert E. Cauley, Chairman and Chief Executive Officer of the company, said in a statement. Cauley added that Orchid Island’s portfolio is weighted towards premium coupon pass-through, interest-only, and inverse interest-only residential mortgage-backed securities, which are highly sensitive to prepayment rates. The reduced dividend brings the firm’s pay-out rate more closely in-line with the premium amortization that the financial firm is currently experiencing in its portfolio. Orchid Island has an estimated total return on equity for the quarter ended June 30, 2015 of 0.4%, or 1.6% on an annualized basis. Year-to-date, the stock has declined by 27% and in the past 12 months, the stock has dipped slightly more, by 28%. Shares of Orchid Island Capital experienced another drop in the last two weeks of June as mortgage real estate investment trusts were squeezed.

Orchid Island Capital Inc (ORC), NYSE:ORC, Yahoo Finance,

The reduced dividend for July 2015 coincides with reduced enthusiasm from hedge funds in the first quarter. By the end of the first quarter, a total of six of the hedge funds tracked by Insider Monkey were long in this stock, up 20% from one quarter earlier, which may be read as a bullish sign on its own. However, it should be noted that the total value of their holdings decreased by 12.73% to $4.48 million by the end of March from $5.13 million at the end of December, even though the stock appreciated by 1.46%. This is a clear bearish sign from the hedge fund crowd.

We pay attention to hedge funds’ moves because our research has shown that hedge funds are extremely talented at picking stocks on the long side of their portfolios. It is true that hedge fund investors have been underperforming the market in recent years. However, this was mainly because hedge funds’ short stock picks lost a ton of money during the bull market that started in March 2009. Hedge fund investors also paid an arm and a leg for the services that they received. We have been tracking the performance of hedge funds’ 15 most popular stock picks in real time since the end of August 2012. These stocks returned 135% since then and outperformed the S&P 500 Index by 80 percentage points (see more details here). That’s why we believe it is important to pay attention to hedge fund sentiment. Plus, we also don’t like paying huge fees.

We also pay attention to insider transactions, to see whether executives inside these companies are confident in their firm’s shares. Director Frank Filipps bought 661 shares on April 6. Director Ava Parker bought 732 shares, also on the same date. President and CEO Robert Cauley bought a total of 3,000 shares in two transactions on March 31.

With all of this in mind, let’s analyze how hedge funds have treated Orchid Island Capital Inc. in the first quarter.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!